Kura Oncology Inc (KURA) financials · rev $67.5M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Kura Oncology Inc (KURA) rev $67.5M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $67.5M | $53.9M |
| Operating Income | -$303.6M | -$193.2M |
| Net Income | -$278.7M | -$174.0M |
| EPS (Diluted) | -$3.18 | -$2.02 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $738.4M | $760.2M |
| Current Assets | $708.7M | $744.8M |
| Cash & Equivalents | $149.1M | $224.5M |
| Inventory | $413.0K | $0 |
| PP&E | $7.86M | $1.68M |
| Total Liabilities | $564.2M | $346.5M |
| Current Liabilities | $117.0M | $78.7M |
| Short-term Debt | N/A | $2.61M |
| Long-term Debt | $9.71M | $6.92M |
| Total Debt | $9.71M† | $9.52M† |
| Shareholders' Equity | $174.1M | $413.6M |
| Retained Earnings | -$1.17B | -$895.4M |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$64.1M | $134.3M |
| CapEx | $6.64M | $472.0K |
| Investing Cash Flow | -$13.1M | -$101.6M |
| Financing Cash Flow | $1.79M | $154.4M |
| Net Change in Cash | -$75.4M | $187.1M |
| Free Cash Flow | -$70.7M | $133.8M |
FAQ
What is KURA P/E and revenue?
Kura Oncology Inc (KURA) rev $67.5M.
What is KURA revenue?
Kura Oncology Inc last cached revenue is $67.5M (FY2025).
Is KURA profitable?
Kura Oncology Inc last cached net income is -$278.7M (FY2025).
What are KURA total assets?
Kura Oncology Inc last cached total assets are $738.4M (FY2025).
What is KURA free cash flow?
Kura Oncology Inc last cached free cash flow is -$70.7M (FY2025).
Not investment advice. Cached statements, not a live tape.